PharmaShots | Incisive News in 3 Shots

Subscribe Now

Triple Class

$Oncopeptides' Pepaxto (melphalan flufenamide) Receives the US FDA's Approval for Triple Class Refractory Multiple Myeloma$

Oncopeptides' Pepaxto (melphalan flufenamide) Receives the US FDA's Approval for Triple Class Refractory Multiple Myeloma

March 1, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us